The Treatment of Cardiovascular Disease: Legacy and Innovation
Topic I. CORONARY ARTERY DISEASE
| 1 - Key Topics in Coronary Artery Disease |
|
| Debate: DES, BMS, or Medical Therapy in Stable Ischemic Heart Disease |
Chaitman |
| Debate: DES, BMS, or Medical Therapy in Stable Ischemic Heart Disease |
Holmes |
| Evaluating Percutaneous Interventions for TraditionalSurgical Indications |
Teirstein |
| Perioperative Risk of Patients with Previous DES Placement |
Ellis |
| What’s New in Coronary Surgery? |
Sabik |
| Preventing Clots in Ischemic Heart Disease |
Lincoff |
| 2 - Management of Acute MI and Shock |
|
| Delays in Door-to-Balloon Time and the Impact on Choice of Therapy |
Bates |
| CABG in Cardiogenic Shock: Patient Selection |
Sabik |
| Circulatory Support in the Cath Lab: Saving Lives or Spending Money |
Kapadia |
| Panel Discussion |
|
| 3 - Technical Advances in PCI |
|
| Magnetic Resonance Guided PCI Van Geuns The Role of Rotational Angiography |
Carroll |
| 4 - The Gold Standard in the Treatment of CAD: PCI vs. CABG |
|
| What is the Data on Restenosis? |
Holmes |
| What is the Data on Graft Patency? |
Sabik |
| Case Presentations: Surgery vs. Stents vs. Medicine |
Starling |
| Case Presentations Part 2: Surgery vs. Stents vs. Medicine |
Sabik |
Topic II. PREVENTION
| 1 - Key Topics in Prevention |
|
| Plaque Regression: Can We Make Atherosclerosis Go Away? |
Nissen |
| HDL Targeted Therapy -- Which Drugs and Why |
Hazen |
| Does Non-Invasive Imaging Prevent Death? - Pro |
Garcia |
| Does Non-Invasive Imaging Prevent Death? - Con |
Lauer |
| Panel Discussion |
|
| 2 - What is the Role of Alternative Blood and Genetic Markers in Preventive Cardiology? |
|
| Blood Markers |
Ridker |
| Genetic Markers |
McPherson |
| Panel Discussion |
|
| 3 - Ask the Experts |
|
| Complex Lipid Cases |
Hazen |
| Women and Heart Disease |
Mayer-Sabik |
| Women and the Cardiac X Syndrome |
Huang |
| Panel Discussion |
|
Topic III. VALVULAR DISEASE
| 1 - Key Topics in Valvular Disease |
|
| Asymptomatic 4+ MR with Prolapse -- Should We Operate? |
Bonow |
| Repair of Ischemic MR -- the Substrate and the Challenges |
Miller |
| Percutaneous Repair for MR -- Ready for Prime Time? |
Carabello |
| Transcatheter AVR -- Which Patients, Which Approach? |
Kapadia |
| Valve-Sparing Root Surgery -- What Has Time Taught Us? |
David |
| Tissue Valves in Young Patients -- The Right Choice? |
Smedira |
| The Treatment of Valve Endocarditis |
Pettersson |
| Panel Discussion |
|
| 2 - Minimally Invasive Mitral Repair |
|
| Anterior Leaflet Repair |
David |
| Robotic Mitral Repair |
Mihaljevic |
| Minimally Invasive Mitral Repair -- Is It Better? |
Gillinov |
| Surgery for Ischemic Mitral Regurgitation |
Kron |
| Panel Discussion |
|
| 3 - Advances in Imaging and Assessment of Valvular Heart Disease |
|
| Quantitative Doppler in MR: Threshold for Repair Stewart 3D Echo in Valve Disease |
Thomas |
| Quantitative Doppler in AR: Threshold for Surgery? |
Bonow |
| Panel Discussion |
|
| 4 - Percutaneous Valve Technologies |
|
| Transcatheter Aortic Valves: How to Do It |
Svensson |
| Transcatheter AVR will Change the Practice of Valve Disease |
Carabello |
| Percutaneous Repair for MR: How Long Until It’s Ready? |
Kapadia |
| Imaging for Percutaneous AVR and MV Repair |
Rodriguez |
Topic IV. AORTIC
| 1 - Key Topics in Aortic |
|
| Past, Present, and Future Concepts for AAA Repair |
Eagleton |
| Contrast Between Open and Endovascular Repair Of Thoracoabdominal Aneurysms |
Roselli |
| Hybrid Graft Solutions and Brain Protection for Arch Repair |
Svensson |
| Panel Discussion |
|
| 2 - Imaging & Patient Workup |
|
| Advances in Aortic CT Imaging |
Flamm |
| Comprehensive Work Up of Aortic Patients Isselbacher Marfans and Other Genetic Disorders: Implications and Testing Efforts |
Moran |
| 3 - How I Do It |
|
| ETG Open and Hybrids |
Svensson |
| ETA Completio |
Roselli |
| Aortic Dissection |
Soltesz |
| 4 - Aortic Debates |
|
| Part 1 |
Reilly |
| Part 2 |
Cambria |
| Part 3 |
Kouchoukos |
| Part 4 |
Cambria |
Topic V. VASCULAR
| 1 - Key Topics in Vascular |
|
| CEA is the Gold Standard |
Hertzer |
| Carotid Stenting is the First line of Therapy For Carotid Stenosis |
Clair |
| Medical Therapy -- No Case for Intervention |
Jaff |
| Panel Discussion |
|
| Intervention Indicated in the Endovascular Era |
Gray |
| Medical Management is the Only Therapy |
Gornik |
| Panel Discussion |
|
| 2 - Management of Venous Thromboembolism |
|
| (VTE) Diagnosis and Management of Acute PE Standard Anticoagulation for VTE |
Bartholomew |
| Thrombolytic Therapy for Acute PE |
Weitz |
| Thrombolytic Therapy/Intervention for DVT |
Comerota |
| Surgical Treatment of Acute and Chronic Pulmonary Emboli |
Gonzalez-Stawinski |
| New Oral Anticoagulants |
Weitz |
| Thrombophilia (Genetic/Acquired) |
Marchant |
| 3 - Management of Lower Extremity Arterial Disease |
|
| PAD and Unusual Vasculopathies |
Olin |
| Tibial Interventions |
Lyden |
| The Superficial Femoral Artery - Interventions and Clinical Data |
Sarac |
| The Treatment of SFA Disease |
Kramer |
| Panel Discussion |
|
| 4 - Management of Cerebral Vascular Disease |
|
| Carotid Duplex-The Gold Standard |
Gornik |
| Cerebral Protection Devices |
Bajzer |
| Vertebral Interventions: The Ignored Problem |
Berguer |
| Percutaneous Vertebral Interventions |
Srivastava |
| Unusual Carotid Disorders |
Jaff |
| Panel Discussion |
|
Topic VI. ELECTROPHYSIOLOGY
| 1 - Collaborative Approach to Electrical |
|
| Therapy of Heart Failure Identification of Patients at Risk of Sudden Cardiac Death |
Estes |
| LV Function, LV Scar & Dyssynchrony in SCD |
Desai |
| Electrical Measurements & Derivative |
Exner |
| Panel Discussion |
|
| Bringing the Preop Assessment into the EP Lab |
Grimm |
| Troubleshooting Optimized CRT |
Mullens |
| Remote Disease Management 2.0 |
Wilkoff |
| 2 - Atrial Fibfillation: Pathophysiology |
|
| Cellular Insights into Atrial Fibrillation |
Van Wagoner |
| 3 - Atrial Fibrilation: Management |
|
| Rate vs. Rhythm Control: The Ongoing Struggle |
Page |
| New Imaging & Navigation Modalities |
Reddy |
| Surgical Ablation: When, Why and How? |
Gillinov |
| Monitoring for Outcomes: Implanted, Wearable |
Lindsay |
| Panel Discussion |
|
| 4 - Collaborative Management of Device Therapy Morbdity: Prevention, Protection & Therapy |
|
| Vascular Occlusion: Detection & Therapy |
Bhatt |
| Infection: Pathophysiology, Prophylaxis & Therapy |
Gordon |
| Lead Failure: Pathophysiology, Prevention & Detection |
Wilkoff |
Topic VII. HEART FAILURE
| 1 - Therapy for Heary Failure: Today and Tomorrow |
|
| Medical Therapies and Personalized Delivery of Care with Genomics |
Bristow |
| Current Indications and Outcomes in Heart and Lung Transplantation |
Taylor |
| Panel Discussion |
|
| 2 - Controversies in Heart Failure Care |
|
| Is Tailored Therapy with a PA Catheter Beneficial? -- Pro -- |
Tang |
| Is Tailored Therapy with a PA Catheter Beneficial? -- Con - |
Rogers |
| Heart Transplant Center Volume: Does Size Matter for Quality Outcomes? -- Pro -- |
Conte |
| Heart Transplant Center Volume: Does Size Matter for Quality Outcomes? -- Con -- |
Sun |
| Does Exercise Help Patients with Heart Failure? -- Pro -- |
O’Connor |
| Does Exercise Help Patients with Heart Failure? -- Con -- |
Lauer |
| 3 - Treatment of Advanced Cardiopulmonary Failure |
|
| Advanced Lung Failure: ECMO Bridge to Lung Transplant |
Mason |
| Pulmonary Hypertension: When to Choose Heart Transplant, Heart/Lung Transplant or VAD Support |
McCurry |
| 4 - Ventricular Assist Devices as a Therapy for Advanced Heart Failure |
|
| The Evolution of VADS: Past, Present and Future |
Copeland |
| What Have We Learned About Continuous Flow Pumps? |
Slaughter |
| Current Outcomes |
Starling |
| Can VADs and Medicines Facilitate LV Recovery? |
Young |
Topic VIII. IMAGING
| 1 - Imaging for Viability: Why is it Important? |
|
| Echo |
Jaber |
| Role of Nuclear Imaging |
Cerqueira |
| CCT and CMR for Viability |
Garcia |
| Panel Discussion |
|
Topic IX. HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
| 1 - Imaging for Viability: Why is it Important? |
|
| Imaging in HOCM |
Desai |
| Percutaneous Therapy for HOCM |
Tuzcu |
| Surgical Therapy for HOCM |
Schaff |
| Mitral Valve Surgery for HOCM |
Smedira |
| Panel Discussion |
|
Topic X. HEART-BRAIN MEDICINE
| 1 - Heart-Brain Medicine |
|
| The Risk of Depression in the CABG Population |
Pozuelo |
| The Role of Biofeedback in the Treatment of Heart Failure |
Moravec |
End